For the year ending 2025-12-31, XFOR has $290,461K in assets. $104,171K in debts. $217,049K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 217,049 | |||
| Accounts receivable | 573 | |||
| Marketable securities | 35,949 | |||
| Research and development incentive receivable | 0 | |||
| Inventory | 4,479 | |||
| Prepaid expenses and other current assets | 3,527 | |||
| Total current assets | 261,577 | |||
| Property and equipment, net | 182 | |||
| Goodwill | 17,351 | |||
| Intangible asset, net | 9,250 | |||
| Right-of-use assets | 1,409 | |||
| Other assets | 692 | |||
| Total assets | 290,461 | |||
| Accounts payable | 5,696 | |||
| Accrued expenses | 18,603 | |||
| Deferred revenue | 464 | |||
| Current portion of lease liability | 994 | |||
| Total current liabilities | 25,757 | |||
| Long-term debt, including accretion, net of discount | 76,291 | |||
| Lease liabilities | 0 | |||
| Warrant liability | 977 | |||
| Deferred revenue | 621 | |||
| Other liabilities | 525 | |||
| Total liabilities | 104,171 | |||
| Common stock, 0.001 par value, 500,000,000 shares authorized as of december31, 2025 and december31, 2024 90,906,920 and 5,698,231 shares issued and outstanding as of december31, 2025 and december31, 2024, respectively | 91 | |||
| Additional paid-in capital | 780,862 | |||
| Accumulated other comprehensive loss | -109 | |||
| Accumulated deficit | -594,554 | |||
| Total stockholders equity | 186,290 | |||
| Total liabilities and stockholders equity | 290,461 | |||
X4 Pharmaceuticals, Inc (XFOR)
X4 Pharmaceuticals, Inc (XFOR)